Publisert 23.05.2018

Innovation Norway grants Innovation Contract to Regenics AS

Regenics AS was May 18th 2018 awarded an Innovation Contract from Innovation Norway. The Innovation Contract has a total budget of 14.3 million NOK to support the development of Vernex® wound healing technology. The project is a collaborative development project. 


Regenics has been granted an Innovation Contract (OFU-T 621) with  a total budget of 14.3 million NOK (case no. 2018/101671). Innovation Contracts is granted to innovative "near market" solutions with international potential. 

The Innovation Contracts are Research & Development contracts with the aim of developing solutions that are unique in the market place.

For more info on Innovation Contracts from Innovation Norway


Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.